These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9536461)

  • 61. Localization of rat striatal monoamine oxidase activities towards dopamine, serotonin and kynuramine by gradient centrifugation and nigro-striatal lesions.
    Van der Krogt JA; Koot-Gronsveld E; Van den Berg CJ
    Life Sci; 1983 Aug; 33(7):615-23. PubMed ID: 6877035
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A study of the biological pharmacology of IFO, a new selective and reversible monoamine oxidase-B inhibitor.
    Matsumoto J; Takahashi T; Agata M; Toyofuku H; Sasada N
    Jpn J Pharmacol; 1994 May; 65(1):51-7. PubMed ID: 8089930
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Platelet and brain GABA-transaminase and monoamine oxidase activities in patients with complex partial seizures.
    Kumlien E; Sherif F; Ge L; Oreland L
    Epilepsy Res; 1995 Feb; 20(2):161-70. PubMed ID: 7750512
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Inhibition of rat brain monoamine oxidase activity by cerebral anti-ischemic agent, ifenprodil.
    Arai Y; Nakazato K; Kinemuchi H; Tadano T; Satoh N; Oyama K; Kisara K
    Neuropharmacology; 1991 Jul; 30(7):809-12. PubMed ID: 1922690
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Type B monoamine oxidase activity in human brain malignant tumors.
    Marcozzi G; Befani O; Mondovì B
    Cancer Biochem Biophys; 1998 Oct; 16(3):287-94. PubMed ID: 10072212
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Design, synthesis, and pharmacological evaluation of 2-amino-5-nitrothiazole derived semicarbazones as dual inhibitors of monoamine oxidase and cholinesterase: effect of the size of aryl binding site.
    Tripathi RKP; M Sasi V; Gupta SK; Krishnamurthy S; Ayyannan SR
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):37-57. PubMed ID: 29098902
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Perinatal co-exposure to methylmercury and PCB153 or PCB126 in rats alters the cerebral cholinergic muscarinic receptors at weaning and puberty.
    Coccini T; Roda E; Castoldi AF; Goldoni M; Poli D; Bernocchi G; Manzo L
    Toxicology; 2007 Aug; 238(1):34-48. PubMed ID: 17618726
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Brain regional distributions of monoamine oxidase activities in postnatal development in normal and chronically manganese-treated rats.
    Leung TK; Lim L; Lai JC
    Metab Brain Dis; 1993 Sep; 8(3):137-49. PubMed ID: 8272026
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Block of 45Ca uptake into synaptosomes by methylmercury: Ca++- and Na+-dependence.
    Shafer TJ; Atchison WD
    J Pharmacol Exp Ther; 1989 Feb; 248(2):696-702. PubMed ID: 2918475
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effects of cadmium and mercury on Na(+)-K+, ATPase and uptake of 3H-dopamine in rat brain synaptosomes.
    Rajanna B; Hobson M; Harris L; Ware L; Chetty CS
    Arch Int Physiol Biochim; 1990 Oct; 98(5):291-6. PubMed ID: 1708997
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Inhibition of glutamate uptake in rat brain synaptosome by methylmercury].
    Zhu W; Chen X
    Wei Sheng Yan Jiu; 1999 Jul; 28(4):196-7. PubMed ID: 11938972
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of manganese on biogenic amine metabolism in regions of the rat brain.
    Subhash MN; Padmashree TS
    Food Chem Toxicol; 1991 Aug; 29(8):579-82. PubMed ID: 1894225
    [TBL] [Abstract][Full Text] [Related]  

  • 73. No changes in lymphocyte muscarinic receptors and platelet monoamine oxidase-B examined as surrogate central nervous system biomarkers in a Faroese children cohort prenatally exposed to methylmercury and polychlorinated biphenyls.
    Coccini T; Manzo L; Debes F; Steuerwald U; Weihe P; Grandjean P
    Biomarkers; 2009 Mar; 14(2):67-76. PubMed ID: 19330584
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Inhibition of monoamine oxidase isoforms modulates nicotine withdrawal syndrome in the rat.
    Malin DH; Moon WD; Goyarzu P; Barclay E; Magallanes N; Vela AJ; Negrete AP; Mathews H; Stephens B; Mills WR
    Life Sci; 2013 Oct; 93(12-14):448-53. PubMed ID: 23988853
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
    Lamensdorf I; Youdim MB; Finberg JP
    J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Evidence for existence of A and B form monoamine oxidase in mitochondria from dog platelets.
    Obata T; Egashira T; Yamanaka Y
    Jpn J Pharmacol; 1987 Jun; 44(2):105-11. PubMed ID: 3116304
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Oxidation of N-methyl-1,2,3,4-tetrahydroisoquinoline into the N-methyl-isoquinolinium ion by monoamine oxidase.
    Naoi M; Matsuura S; Parvez H; Takahashi T; Hirata Y; Minami M; Nagatsu T
    J Neurochem; 1989 Feb; 52(2):653-5. PubMed ID: 2911035
    [TBL] [Abstract][Full Text] [Related]  

  • 78. MDL 72,974A: a selective MAO-B inhibitor with potential for treatment of Parkinson's disease.
    Palfreyman MG; McDonald IA; Zreika M; Cremer G; Haegele KD; Bey P
    J Neural Transm Suppl; 1993; 40():101-11. PubMed ID: 8294896
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Activation of monoamine oxidase by high molecular weight fractions of human plasma.
    Wahlund LO; Sääf J; Ross SB; Wetterberg L
    Acta Physiol Scand; 1984 Mar; 120(3):337-41. PubMed ID: 6741571
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B.
    Youdim MB; Gross A; Finberg JP
    Br J Pharmacol; 2001 Jan; 132(2):500-6. PubMed ID: 11159700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.